Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and betadex

gefitinib has been researched along with betadex in 5 studies

Compound Research Comparison

Studies
(gefitinib)		Trials
(gefitinib)		Recent Studies (post-2010)
(gefitinib)		Studies
(betadex)		Trials
(betadex)		Recent Studies (post-2010) (betadex)
5,2315662,9198,785974,452

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boerner, JL; Bohin, N; Ge, Y; Irwin, ME; Mueller, KL1
Hu, X; Huang, Y; Lee, RJ; Li, H; Xiang, G; Yung, B; Zhou, X1
Cui, W; Feng, B; Li, H; Liu, L; Liu, M; Shi, Y; Su, C; Su, R; Zhao, L1
Abbas, A; Basak, S; Bhattacharya, P; Deep Punetha, V; Dey, S; Gopal Sahoo, N; Mondal, S; Saha, A1
Deep Kaur, C; Gidwani, B; Vyas, A1

Other Studies

5 other study(ies) available for gefitinib and betadex

ArticleYear
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
    Journal of cellular physiology, 2011, Volume: 226, Issue:9

    Topics: Atorvastatin; Benzylamines; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; ErbB Receptors; Female; Gefitinib; Heptanoic Acids; Humans; Lovastatin; Membrane Microdomains; Phosphorylation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Thiophenes

2011
Novel liposomal gefitinib (L-GEF) formulations.
    Anticancer research, 2012, Volume: 32, Issue:7

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Drug Stability; Gefitinib; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Inbred ICR; Particle Size; Quinazolines

2012
Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
    Journal of nanobiotechnology, 2014, Oct-30, Volume: 12

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Autophagy; beta-Cyclodextrins; Cell Survival; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Gefitinib; HeLa Cells; Humans; Molecular Targeted Therapy; Nanoparticles; Quinazolines; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared

2014
Fabrication of β-cyclodextrin-mediated single bimolecular inclusion complex: characterization, molecular docking, in-vitro release and bioavailability studies for gefitinib and simvastatin conjugate.
    The Journal of pharmacy and pharmacology, 2017, Volume: 69, Issue:10

    Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; beta-Cyclodextrins; Biological Availability; Drug Carriers; Drug Compounding; Drug Liberation; Female; Gefitinib; Male; Mice; Molecular Docking Simulation; Quinazolines; Rats, Wistar; Simvastatin; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2017
Investigation of inclusion behaviour of gefitinib with epichlorohydrin-β-cyclodextrin polymer: preparation of binary complex, stoichiometric determination and characterization.
    Journal of pharmaceutical and biomedical analysis, 2018, Oct-25, Volume: 160

    Topics: Antineoplastic Agents; beta-Cyclodextrins; Calorimetry, Differential Scanning; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Epichlorohydrin; Freeze Drying; Gefitinib; Polymers; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2018